What the FT3 Community Made Possible in 2024
Real-world progress in personalized medicine, powered by collaboration.
Executive summary
Precision medicine holds the promise of more targeted treatments, faster diagnoses, and better outcomes, starting in oncology. But its full potential can only be realized through collective action.
In 2024, FT3 partners demonstrated that change is not only possible, it’s already happening. From integrating patient experience data into decision-making frameworks to addressing barriers in access and affordability, the work happening across the FT3 network has delivered tangible impact.
This report captures those advances: not as a list of activities, but as evidence of how shared commitment can lead to systemic transformation. It is also a call to action, to continue working together so that everyone who can benefit from personalised approaches to care, does.
The PM community has inspired FT3 to create a space where those who are passionate about bringing precision medicine to everyone who can benefit from it can make a real difference.
None of this would have been possible without you, the ever growing active community of opinion leaders, supporters, sponsors that make all this impact possible.
Breaking down barriers to Personalized Medicine
How the FT3 community helped make a difference in 2024
Delivering the right care, at the right time, and how we helped
In 2024, FT3 partners turned ambition into action, co-creating solutions that are already shaping access, advocacy, and adoption across Europe.
Partners strengthened local capacity to influence how personalised healthcare is understood and prioritized.
Built on
30+
Good practice resources and evidence
Pilot to be expanded to additional countries in 2025
50+
Local champions co-developed an FT3 Advocacy Roadmap
40
Champions equipped with tailored policy messages & case studies
FT3 created space for patient-led insights to shape value assessment and system innovation.
Partnerships with ISPOR and HTAi aligned efforts across disciplines
Advocated for PED inclusion in health technology assessments and drug development
100+
Stakeholders engaged in FT3 sessions at Patient Engagement Open Forum
FT3 partners bridged the gap between evidence and implementation to enable system-wide change.
Supported integration of value-based frameworks that reflect patient realities
Connected evidence, evaluation, and access in real-world settings
Multi-country study executed on post-HTA adoption of novel value drivers
Transforming Care Where It Matters Most
FT3 helps champions adapt and apply personalized healthcare tools at the point of care, wherever they are in the world.
“FT3 is focused on breaking down systemic barriers to PM by giving champions the necessary tools to drive change.”
Barriers to PM exist everywhere, but may look different depending on where you are.
FT3’s “global local” approach allows resources and tools to be quickly and easily adapted for use anywhere
70%
of surveyed patients reported increased awareness of targeted therapies
In Canada, PM education tools expanded into new disease areas
In Nigeria, 3 PM education tools were adapted and piloted. The result? 70% of surveyed patients reported increased awareness of targeted therapies.
Tools improved patient-provider conversations around personalised treatment
A patient-friendly biomarker test summary is helping close the communication gap.
Now piloted in Italy and Argentina
Aims to make genomic test results easier to understand and act on
Co-created with patients and providers
FT3 mapped the barriers healthcare professionals face in implementing personalised care, and offered insights for change.
Reviewed
50+
Resources and 46 initiatives
Findings published in Cancer Medicine and shared at ESMO 2024
Scoping review on biomarker communication reached
3000+
Views
Interviewed
60+
Nurses across multiple countries
Strengthening the Global Personalized Medicine Ecosystem
PM Synapse serves as a vehicle to drive various FT3 project streams to success, providing a unique forum for all stakeholders with an interest in PM endeavours.
An open-access platform built for collaboration, accelerating peer-to-peer learning, visibility, and real-world implementation.
605
individuals and 852 organizations connected
Supports collaboration across geographies, sectors, and disciplines
1,385
shared resources spanning 135 disease areas
Pilots That Deliver Local Impact with Global Relevance
FT3 supports tailored solutions to real access barriers through country-led pilots that can inform scalable change.
A regional policy roundtable convened stakeholders across the health ecosystem, clinicians, policymakers, and patient advocates, to co-create a roadmap for accelerating PM.
Raised awareness among
1,000+
patients
Engaged multiple medical societies
Outcomes included commitments to education, biomarker testing pathways, and alignment on access goals
FT3 supported the integration of personalised medicine materials into routine care across 140+ clinics, covering both rural and urban regions.
Reached frontline HCPs, nurses, and local health managers
Materials supported more informed patient-provider dialogue and uptake of biomarker testing
A multi-stakeholder collaboration, including clinicians, patients, and policymakers, mapped access barriers across the entire lung cancer pathway.
Findings included diagnostic delays, financial barriers, and inconsistent data use
Insights now informing future implementation planning and advocacy
Building Leadership Across the Ecosystem
FT3 fosters communities of practice and builds bridges across roles and regions to unlock real change.
FT3 facilitated collaboration between oncology nurses, pathologists, medical societies, and advocacy leaders
Discussions helped surface practical solutions to improve understanding and communication of PM at the clinical level
Focused on ensuring frontline professionals are part of the precision medicine conversation
Two virtual multi-stakeholder sessions convened FT3 champions from around the world
Delivered practical tools and case studies to address access and implementation challenges
Created a platform for continued learning, local adaptation, and shared accountability
Looking Ahead to 2025: Scaling Local Impact for Global Change
FT3’s progress in 2024 was made possible by the people and organizations driving real change in their communities. Our role remains to support, amplify, and connect them, so together, we can make personalised healthcare the norm, not the exception.
Scaling what’s working by empowering more communities to adapt tools, build coalitions, and influence policy.
New pilots planned in Romania and Poland focused on embedding PM into regional care pathways
Expansion of the Advocacy Roadmap and patient-friendly tools to more local champions
More collaboration with local health authorities to align on implementation priorities
Turning insights into systems-level adoption through smarter use of data, partnerships, and implementation frameworks.
Exploring pathways to integrate PM into national health planning and reimbursement
Broaden use of patient experience data to support access decisions
New partnerships to connect biomarker strategies with real-world outcomes
Enabling people, not platforms, to drive the shift toward personalised, data-informed care.
Expand FT3’s Communities of Practice, focusing on oncology nurses, diagnostics leads, and health system influencers
Launch precision advocacy learning modules co-developed with partners
Invest in more visibility opportunities for local leaders to tell their stories
Can You Help Break Down These Barriers?
Whether you’re a policymaker, clinician, patient advocate, or MedTech innovator, your work is already part of the solution.
Now Is the Time to Engage
FT3 is not just a program, it’s a proof point that collaborative, patient-centered innovation can work. If your mission aligns with equitable access, smarter systems, and better outcomes, we want to work with you.
- Join our pilot initiatives in 2025
- Contribute your expertise to Communities of Practice
- Use the tools developed by and for PM champions
- Reach out to explore partnership opportunities or join the FT3 network
Our Financial Footprint in 2024 [k€]
Turnover
1,118
Program Expenses
1,118
How We Allocated Our Resources
59.34%
Building a robust and impactful organization
20.74%
Building evidence & resources
18.50%
Building awareness & conditions for better access
1.43%
Other
- of Total Expenses
- Strategic Area
Made possible by our partners and contributors
Made possible by our
partners and contributors
